FAIRFIELD, CONN., December 18, 2006 – IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced that it is acquiring the Life Sciences practice of Strategic Decisions Group (SDG), the leader in portfolio strategy consulting to the pharmaceutical and biotech industries. Terms of the transaction were not disclosed.
